Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
KAZIA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES HOSTED BY HC WAINWRIGHT AND LD MICRO 2022-05-23 20:30
VISEN Pharmaceuticals Announces Top-line Results of Phase 3 Trial of Once-Weekly Lonapegsomatropin, Demonstrating Superior Efficacy, Comparable Safety and Tolerability to Daily Growth Hormone 2022-05-23 15:57
Hanmi Fine Chemical Launches 'high-tech CDMO' Business 2022-05-23 08:32
WHO Goodwill Ambassador for Leprosy Elimination Recognized with WHO Director-General's Award for Global Health at 75th World Health Assembly 2022-05-23 00:00
Meihua International Medical Technologies Co., Ltd. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 20-F 2022-05-20 22:57
CBC Welcomes Former Allergan CEO Brent Saunders to Join Hugel Board as Executive Chair 2022-05-20 15:00
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-05-19 22:39
I-Mab to Hold Investor Call to Report Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab 2022-05-19 20:00
Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib's Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine 2022-05-18 22:06
OriCiro Genomics expand into Boston, Open new office in North America 2022-05-18 22:00
Laekna Therapeutics Raises $61 Million in Series D financing 2022-05-18 20:00
Ping An Overseas Holdings Announces Successfully Raising USD 300 Million for China New Economy Fund 2022-05-18 16:15
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes 2022-05-17 22:00
"VR Hands-On Training" -- Live-Action Clinical Training with Hand Tracking Selected as a Finalist for AWE Auggie Awards, the World's Biggest VR/AR Awards! 2022-05-17 21:00
Indonesia to lead explore ASEAN Health Sector Cooperation with the US 2022-05-17 20:05
KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE 2022-05-17 20:00
GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia 2022-05-16 09:00
Kintor Pharma Included in MSCI China Index 2022-05-15 18:28
Dizal Announces New Data from the Phase I/II Study of Golidocitnib in Refractory or Relapsed Peripheral T Cell Lymphoma Selected for Oral Presentation at 2022 EHA Annual Meeting 2022-05-13 19:09
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria 2022-05-12 22:43
1 158 159 160 161 162 801